Disproportionate infection, hospitalisation and death from COVID-19 in ethnic minority groups and Indigenous Peoples: an application of the Priority Public Health Conditions analytical framework.

Patricia Irizar, Daniel Pan, Harry Taylor, Christopher A Martin, Srinivasa Vittal Katikireddi, Niluka Wijekoon Kannangarage, Susana Gomez, Daniel La Parra Casado, Prashanth Nuggehalli Srinivas, Finn Diderichsen, Rebecca F Baggaley, Laura B Nellums, Theadora Swift Koller, Manish Pareek
Author Information
  1. Patricia Irizar: Faculty of Humanities, School of Social Sciences, University of Manchester, UK.
  2. Daniel Pan: Department of Respiratory Sciences, University of Leicester, UK.
  3. Harry Taylor: Department of Global Health and Social Medicine, King's College London, UK.
  4. Christopher A Martin: Department of Respiratory Sciences, University of Leicester, UK.
  5. Srinivasa Vittal Katikireddi: MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, UK.
  6. Niluka Wijekoon Kannangarage: World Health Organization, Geneva, Switzerland.
  7. Susana Gomez: World Health Organization, Geneva, Switzerland.
  8. Daniel La Parra Casado: Department of Sociology, University of Alicante, Spain.
  9. Prashanth Nuggehalli Srinivas: Institute of Public Health, Bengaluru, India.
  10. Finn Diderichsen: University of Copenhagen, Copenhagen, Denmark.
  11. Rebecca F Baggaley: Leicester NIHR Biomedical Research Centre, UK.
  12. Laura B Nellums: Lifespan and Population Sciences, School of Medicine, University of Nottingham, UK.
  13. Theadora Swift Koller: World Health Organization, Geneva, Switzerland.
  14. Manish Pareek: Department of Respiratory Sciences, University of Leicester, UK.

Abstract

The COVID-19 pandemic has resulted in disproportionate consequences for ethnic minority groups and Indigenous Peoples. We present an application of the Priority Public Health Conditions (PPHC) framework from the World Health Organisation (WHO), to explicitly address COVID-19 and other respiratory viruses of pandemic potential. This application is supported by evidence that ethnic minority groups were more likely to be infected, implying differential exposure (PPHC level two), be more vulnerable to severe disease once infected (PPHC level three) and have poorer health outcomes following infection (PPHC level four). These inequities are driven by various interconnected dimensions of racism, that compounds with socioeconomic context and position (PPHC level one). We show that, for respiratory viruses, it is important to stratify levels of the PPHC framework by infection status and by societal, community, and individual factors to develop optimal interventions to reduce inequity from COVID-19 and future infectious diseases outbreaks.

Keywords

References

  1. Ann Intern Med. 2021 Mar;174(3):362-373 [PMID: 33253040]
  2. SSM Popul Health. 2022 Aug 28;19:101217 [PMID: 36091297]
  3. J Clin Epidemiol. 2020 Dec;128:35-48 [PMID: 32526461]
  4. J Health Monit. 2020 Oct 09;5(Suppl 7):3-17 [PMID: 35146298]
  5. BMJ. 2021 Nov 5;375:n2709 [PMID: 34740938]
  6. Vaccine. 2021 Apr 8;39(15):2024-2034 [PMID: 33722411]
  7. EClinicalMedicine. 2020 Jun 03;23:100404 [PMID: 32632416]
  8. JAMA. 2022 Feb 8;327(6):546-558 [PMID: 35072713]
  9. Fisc Stud. 2020 Jun;41(2):259-289 [PMID: 32836536]
  10. Am J Public Health. 2000 Aug;90(8):1212-5 [PMID: 10936998]
  11. JAMA Intern Med. 2023 Jan 1;183(1):50-60 [PMID: 36469312]
  12. EClinicalMedicine. 2020 Dec;29:100630 [PMID: 33200120]
  13. J Gen Intern Med. 2023 Apr;38(5):1127-1136 [PMID: 36795327]
  14. Nat Commun. 2022 Feb 1;13(1):636 [PMID: 35105869]
  15. Lancet. 2021 May 1;397(10285):1603-1605 [PMID: 33865497]
  16. Eur J Epidemiol. 2021 Mar;36(3):299-309 [PMID: 33587202]
  17. Lancet Reg Health Eur. 2021 Oct;9:100180 [PMID: 34308406]
  18. BMJ. 2022 Mar 23;376:o632 [PMID: 35321937]
  19. Scand J Public Health. 2021 Feb;49(1):14-16 [PMID: 33407002]
  20. Lancet. 2023 Jan 28;401(10373):281-293 [PMID: 36566761]
  21. J Med Ethics. 2021 Dec 17;: [PMID: 34921122]
  22. Lancet Public Health. 2022 Nov;7(11):e966-e975 [PMID: 36334610]
  23. PLoS Med. 2022 May 26;19(5):e1004015 [PMID: 35617423]
  24. Vaccine. 2022 May 31;40(25):3413-3432 [PMID: 35534309]
  25. J Migr Health. 2021;4:100036 [PMID: 33778797]
  26. Br Med Bull. 2007;81-82:21-37 [PMID: 17284541]
  27. J Am Acad Dermatol. 2020 Jul;83(1):e35 [PMID: 32305444]
  28. Nat Commun. 2022 Jun 14;13(1):3277 [PMID: 35701401]
  29. JAMA Netw Open. 2021 Nov 1;4(11):e2134147 [PMID: 34762110]
  30. N Engl J Med. 2020 Oct 8;383(15):1483-1488 [PMID: 32706956]
  31. Du Bois Rev. 2011 Apr;8(1):115-132 [PMID: 25632292]
  32. Int J Equity Health. 2022 Jan 14;21(1):6 [PMID: 35031078]
  33. BMJ Open. 2020 Dec 10;10(12):e041750 [PMID: 33303461]
  34. Metabolism. 2021 Aug;121:154814 [PMID: 34119537]
  35. J Health Care Poor Underserved. 2020;31(4):1530-1535 [PMID: 33416734]
  36. EClinicalMedicine. 2020 Aug;25:100466 [PMID: 32840492]
  37. EClinicalMedicine. 2023 Mar;57:101877 [PMID: 36969795]
  38. Am Behav Sci. 2013 Aug 1;57(8): [PMID: 24347666]
  39. Am J Public Health. 2003 Feb;93(2):277-84 [PMID: 12554585]
  40. Soc Sci Med. 2015 Oct;142:128-35 [PMID: 26301485]
  41. Public Health. 2023 Sep;222:205-214 [PMID: 35970621]
  42. Int J Health Serv. 2021 Oct;51(4):417-422 [PMID: 33635123]
  43. Lancet. 2022 Jan 22;399(10322):355-356 [PMID: 35065780]
  44. Nat Med. 2022 Jul;28(7):1338-1342 [PMID: 35641824]
  45. BMC Health Serv Res. 2022 Jul 5;22(1):867 [PMID: 35790970]
  46. Rev Med Virol. 2022 May;32(3):e2306 [PMID: 34674338]
  47. SSM Popul Health. 2022 Sep;19:101150 [PMID: 35765366]
  48. Lancet Public Health. 2021 Jul;6(7):e445-e446 [PMID: 34174997]
  49. Am J Public Health. 2011 Feb;101(2):285-93 [PMID: 21164098]
  50. Nat Med. 2022 Aug;28(8):1706-1714 [PMID: 35879616]
  51. Public Health Rep. 1980 Sep-Oct;95(5):411-21 [PMID: 7422807]
  52. Health Serv Res. 2012 Jun;47(3 Pt 2):1278-99 [PMID: 22515933]
  53. Community Dent Oral Epidemiol. 2011 Dec;39(6):481-7 [PMID: 21623864]
  54. J Epidemiol Community Health. 2021 Oct;75(10):970-974 [PMID: 33883198]
  55. Arch Bone Jt Surg. 2020 Apr;8(Suppl 1):247-255 [PMID: 32733980]
  56. BMC Public Health. 2023 Jan 6;23(1):47 [PMID: 36609295]
  57. J Psychosom Res. 2021 Jul;146:110434 [PMID: 33810863]
  58. J Racial Ethn Health Disparities. 2021 Dec;8(6):1563-1572 [PMID: 33180278]
  59. Am J Emerg Med. 2022 Feb;52:166-173 [PMID: 34923196]
  60. BMJ Glob Health. 2021 Nov;6(11): [PMID: 34740916]

Grants

  1. 001/World Health Organization
  2. IA/CRC/20/1/600007/DBT-Wellcome Trust India Alliance

Word Cloud

Created with Highcharts 10.0.0PPHCCOVID-19HealthlevelethnicminoritygroupsIndigenousapplicationframeworkinfectionpandemicPriorityPublicConditionsrespiratoryvirusesinfectedinequityresulteddisproportionateconsequencesPeoplespresentWorldOrganisationWHOexplicitlyaddresspotentialsupportedevidencelikelyimplyingdifferentialexposuretwovulnerableseverediseasethreepoorerhealthoutcomesfollowingfourinequitiesdrivenvariousinterconnecteddimensionsracismcompoundssocioeconomiccontextpositiononeshowimportantstratifylevelsstatussocietalcommunityindividualfactorsdevelopoptimalinterventionsreducefutureinfectiousdiseasesoutbreaksDisproportionatehospitalisationdeathPeoples:analyticalEthnicityRaceSARS-CoV-2

Similar Articles

Cited By (1)